Lallemand Bio-Ingredients Submits Yeast Protein for Fi Europe Innovation Awards 2025
Save
Ingredients

Lallemand Bio-Ingredients Submits Yeast Protein for Fi Europe Innovation Awards 2025

Vegconomist • Oct 28, 2025
Lallemand Bio-Ingredients has submitted Engevita® HiPRO Beyond, a yeast-based protein with a protein content of at least 80%, for the Fi Europe Innovation Awards 2025 in the Dairy Alternatives category. This complete protein source contains all essential amino acids, including BCAAs, making it ideal for muscle health and recovery. It is suitable for dairy-like beverages and hybrid dairy products, offering a neutral flavor, light color, and smooth texture that can be seamlessly integrated into various formulations without compromising sensory characteristics.

Engevita® HiPRO Beyond addresses off-flavors and undesirable textures commonly associated with plant-based proteins, providing a clean and balanced sensory profile suitable for sweet and savory applications. Produced through controlled fermentation, this protein does not contain antinutritional factors and offers a more sustainable option compared to traditional plant-based protein sources. Lallemand Bio-Ingredients emphasizes the product's compatibility with consumer preferences for nutritious and sustainable dairy alternatives, enabling developers to create high-quality, better-tasting recipes with a creamy texture.
*This summary was generated using AI.
Read Full Article

Related recipes, books, documentaries, and topics from our catalog.

Heavenly Balsamic Fig Jam

VegNews

Oct 26, 2025

This Wisconsin Grilled Cheese Is 100% Dairy-Free

Plant Based News

Aug 21, 2025

Podcast Episodes

View all podcasts
Vegan Lake Garda | Discover Il Mansio, a Luxury Vegan Hotel | Valentina Mori

The World Vegan Travel Podcast

Jan 12, 2026

Breaking World Records: The Vegan Athlete Who Ran 450 Miles in 108 Hours Straight Harvey Lewis

The Fit Vegan Podcast with Maxime Sigouin

Jul 09, 2024

Community reviews

Sign in to leave the first review.

Discussion Join the conversation

Sign in to start the discussion.